• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Wyeth

Wyeth

Pfizer Inc PFE 2 Star

Last Price$31.94Day Change (%)-0.09%
Open Price$31.91Day Change ($)-0.03
Day Range31.61–32.0952-Week Range27.51–33.12

As of Fri 12/19/2014 07:06 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. Investor or Speculator?

    Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and opioid bowel dysfunction. We are leaving our ...

  2. Roche Names New Genentech R&D Chief

    Roche Names New Genentech R&D Chief

  3. Roche Names New Genentech Chief

    Roche Names New Genentech Chief

  4. What Two Great Managers Are Buying

    Inside Clipper Fund's makeover.

  5. A Shift in Health-Care M&A Activity

    Recent deals have been driven more by tax strategies than therapeutic synergies.

  6. Finding Moats in Big Pharma's Consumer Health Units

    We believe breakups could unlock value for big pharma shareholders.

  7. Health-Care Investing Alive and Well

    Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.

  8. The Future of Big Pharma

    Things look grim, but investors who can bear it could benefit.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.